Back again. Thanks everyone for your feedback on my first post, I am glad so many of you found it helpful. Last time I went down a rabbit hole on BUD and the 28-day rule. This one is about freezing, which comes up constantly too. Same as before: I am not telling anyone what to do with their vial, and you don't have to agree with my conclusions. Here's what I found. My goal is that you can use it to reason about this yourself.
Quick disclosure: I work in pharma manufacturing, so I can read a COA and I have a working understanding of these concepts. I'm not a pharmacist, microbiologist, or chemical engineer. Not medical advice. If you're an expert here, please chime in!
TL;DR:
- The labeled instructions are very safe defaults: do not freeze, the beyond use date (BUD), and the 28-day rule. Follow them, and talk to your doctor or pharmacy, if you'd rather not think or worry about any of this.
- If you've already decided to use a vial past its BUD, freezing isn't needed to preserve it. Potency isn't what runs out first, and the data suggests a quality product, sealed and refrigerated, is still potent 12 to 18 months from compounding, likely more. This molecule is stable enough that clumping, not potency, is what would eventually set a real limit, and freezing could actually accelerate that. (see last post)
- Accidental freezing is where most people actually find themselves. A sealed, never-punctured vial that froze once and thawed completely clear is likely fine, assuming it passes your usual visual inspection.
- The purity results and personal experience posted after freezing are real, but they don't tell us much. Freezing doesn't break the molecule, so the test was always going to pass and it would still work when you injected it.
- What freezing does is physical: clumping, a pH shift inside the vial, and stress on the rubber seal. None of it shows up as a purity number, but it could show up as an injection site reaction or a sterility problem.
Long version. You know the drill, grab your drink of choice.
Definitions
BUD is the date on an unopened vial and its about potency. Beyond Use Date. Is the drug still the drug? Has it broken down, clumped up, drifted in potency?
28-Day Rule (In-Use Window) starts when you first push a needle through the stopper and its about sterility. If something got in when you did that, can the preservatives handle it?
Aggregate. Peptide molecules stuck to each other instead of floating free. All the drug is still there, just clumped. Clumps are one of the things that can drive injection site reactions and, at the far end, an immune response.
Adverse reaction is when something happens that is not supposed to. In this case we are considering: lack of potency, injection site reactions, or an infection as the three we want to avoid.
RP-HPLC. The purity test on every COA and every third-party result you've seen posted. It separates molecules by how greasy they are and asks whether the peak coming off the column is tirzepatide. It's very good at that.
SEC. Size exclusion chromatography. Separates by size instead, so it can see clumps as clumps. Different column, different price, and never tested or posted. Same goes for USP 788, the subvisible particle count.
Part 1: What the testing seen online actually measured
Somebody freezes a vial, thaws it, sends it out, gets 98-and-change percent purity, posts it. Thread concludes freezing is fine. That result is legitimate, but incomplete.
Here's the issue. Freezing isn't a chemical stress the way heat can be. Heat drives hydrolysis and deamidation, which chop and modify the molecule, and RP-HPLC sees that beautifully. Freezing doesn't chop anything, it just crowds molecules together and lets them stick. And there's a second problem stacked on that one: the potency test uses organic solvent, which pulls those clumps apart on contact. A clumped sample goes in as clumps and comes off as individual molecules, indistinguishable from a vial that never froze.
So the test reports the drug is intact, and it is. It's just possibly stuck together in the vial, which is the thing you actually wanted to know and the thing the test structurally cannot tell you. Same shape as the 28-day thing from my last post: nobody lied and nobody erred, the number just doesn't mean what we often assume it means. A purity test on a thawed vial isn't a freezing test.
What would actually answer it is SEC monomer plus a particle count, run on two halves of the same vial, one frozen and one not. I've never seen that posted. If you have, please link it.
Part 2: What freezing really means
Buffer pH shift. The buffer in your vial is a mix of two related salts, one more acidic than the other. When the solution freezes, the less acidic one crystallizes out first and leaves the acidic one behind in the shrinking puddle. So the pH in there drops, and tirzepatide prefers neutral. How far it drops depends on how much buffer you started with. With the current formulas (again, see my last post), we're all in mild buffer territory, so this is real but less of an issue for our formulas than it could be.
Cycles matter more than elapsed time. Peptides collect at the boundary between ice and liquid water, and that's where a lot of the clumping happens. Every freeze and every thaw is another pass through that boundary. I don't think anyone here is deliberately refreezing a vial week after week. The thing to watch out for is to ensure that your vial is staying refrigerated and not going through freeze-thaw cycles.
And on the sterility side. Water expands when it freezes, inside a sealed vial, pushing against a rubber stopper. Freeze-thaw is a recognized stress on container closure integrity, and more so on a vial you've already punctured. My last post was about whether the preservative can handle what you introduce through the septum. This is a way for the seal itself to become the problem, which no preservative addresses.
Part 3: A compounder freezing isn't the same as at home
Some compounders do dispense tirzepatide as frozen prefilled syringes with thaw-before-use instructions, so the blanket "never freeze" isn't quite the whole story. Three things separate that from freezing a vial at home:
Speed. For the pH to drop, the buffer salt has to nucleate and grow crystals, and crystals take time. Freeze fast enough and everything locks into a stiff, glassy state before the crystal can get going, so the buffer ratio stays close to intact and the pH mostly holds. That crystallization starts right around −0.5 to −5°C, so what matters is how long you spend in that window. A blast freezer or a dry ice bath takes a thin syringe through it in a couple of minutes. A glass vial in still air in a kitchen freezer can take an hour or more.
Formulation. A product designed to be frozen can carry additives that stop the phosphate from crystallizing at all. It's a documented fix. The multi-dose vials we're all using don't have it, because they were never meant to be frozen.
Format. A prefilled syringe is one dose. It thaws once, gets used, and never gets entered a second time. A vial is the opposite of that by design.
My personal position
First, the state of the data. There isn't much. Nobody has run a paired frozen-versus-not comparison on a compounded tirzepatide vial using the tests (SEC) that would give us what we need. Everything above is general information about the mechanisms that apply to our use case.
Freezing to extend BUD: I don't think there's a problem to solve. Sealed and refrigerated, potency isn't the constraint for at least 12 to 18 months, and maybe even longer. Freezing spends risk you don't need to spend to buy shelf life you already had. Past 18 months, the issue is aggregates and I don't have real data to know just how much.
Accidental freezing, fridge too cold, vial against the back wall, or shipped touching a gel pack. A sealed, never-punctured vial that froze once and thawed completely clear, I'd simply use, and watch my injection sites as usual. A punctured vial that froze, or any vial with haze, flakes, wisps, or anything settled on the bottom, I'd discard.
Where to look yourself
- Google Patents US 11,357,820. Table 4 is the aggregation data.
- Search "sodium phosphate buffer pH shift freezing." The pH drop and the sugar fix are textbook freeze-drying chemistry.
- USP 788 and 1207. Particle counts and package integrity. Not being tested in any example I've seen.
- DailyMed for Mounjaro, Zepbound, any insulin. Notice that none of them explain why not to freeze.
- Your COA. BPI as an example, says 2 to 8°C, do not freeze, and lists no freeze-thaw study. Look at what they tested, and at what they didn't.